Kiran Aithal Balkudru

Title: The Innovations of Kiran Aithal Balkudru

Introduction

Kiran Aithal Balkudru is a distinguished inventor based in Bengaluru, India. He has significantly contributed to the field of oncology through his innovative solutions, holding a total of 2 patents. His work primarily focuses on the development of novel cancer therapies aimed at improving treatment outcomes for patients.

Latest Patents

Kiran's latest patents revolve around the combination of small molecule CD-47 inhibitors with other anti-cancer agents. The present invention relates to a composition that features a CD47-SIRPα blocking agent, represented by a compound of formula (I), combined with one or more anti-cancer agents. This invention also encompasses a method for treating cancer in a subject by administering a therapeutically effective amount of the CD47-SIRPα blocking agent alongside the anti-cancer agents.

Career Highlights

Throughout his career, Kiran Aithal Balkudru has been associated with prominent companies like Aurigene Discovery Technologies Limited and Aurigene Oncology Limited. His roles in these organizations have allowed him to work on pioneering projects that push the boundaries of cancer treatment.

Collaborations

Kiran has collaborated with several talented individuals in his field, including Muralidhara Ramachandra and Pottayil Govindan Nair Sasikumar. These collaborations have been instrumental in refining his inventions and fostering innovative approaches to cancer therapy.

Conclusion

Kiran Aithal Balkudru's contributions to the innovation landscape in oncology are noteworthy. Through his patents and collaborative efforts, he is making strides towards developing effective treatments for cancer, showcasing the power of innovation in healthcare. His work continues to inspire future generations of inventors and researchers in the field.